Global Asthma & COPD Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 108

Report ID: 6353

Chronic obstructive pulmonary disease (COPD) is a general term that describes progressive respiratory diseases like emphysema and chronic bronchitis. COPD is characterized by decreased airflow over time, as well as inflammation of the tissues that line the airway.
Asthma is usually considered a separate respiratory disease, but sometimes it’s mistaken for COPD. The two have similar symptoms. These symptoms include chronic coughing, wheezing, and shortness of breath.
Currently, North America leads the global market for asthma & COPD drugs and devices. North America was followed by Europe in terms of market capitalization. However, North America and Europe is expected to lose out some of the market share to other emerging regional markets owing to the expiry of several patens of pharmaceutical companies operating in these regions. Asia Pacific is expected to be the fastest regional market for asthma and COPD owing to the increased incidence of asthma & other respiratory diseases in industrial regions.

The global Asthma & COPD market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Asthma & COPD volume and value at global level, regional level and company level. From a global perspective, this report represents overall Asthma & COPD market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
GSK
Novartis
Merck
Abbott
Boehringer Ingelheim
AstraZeneca
Roche
Teva
Vectura
Pfizer
Mylan
Allergan
Cipla
Akorn

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Anti-inflammatory Drugs
Bronchodilator Monotherapy
Combination Drugs

Segment by Application
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce

Table of Contents

Executive Summary
1 Asthma & COPD Market Overview
1.1 Product Overview and Scope of Asthma & COPD
1.2 Asthma & COPD Segment by Type
1.2.1 Global Asthma & COPD Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Anti-inflammatory Drugs
1.2.3 Bronchodilator Monotherapy
1.2.4 Combination Drugs
1.3 Asthma & COPD Segment by Application
1.3.1 Asthma & COPD Consumption Comparison by Application (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Drug Stores
1.3.5 Retail Pharmacies
1.3.6 E-Commerce
1.4 Global Asthma & COPD Market by Region
1.4.1 Global Asthma & COPD Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Asthma & COPD Market Size
1.5.1 Global Asthma & COPD Revenue (2014-2025)
1.5.2 Global Asthma & COPD Production (2014-2025)

2 Global Asthma & COPD Market Competition by Manufacturers
2.1 Global Asthma & COPD Production Market Share by Manufacturers (2014-2019)
2.2 Global Asthma & COPD Revenue Share by Manufacturers (2014-2019)
2.3 Global Asthma & COPD Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Asthma & COPD Production Sites, Area Served, Product Types
2.5 Asthma & COPD Market Competitive Situation and Trends
2.5.1 Asthma & COPD Market Concentration Rate
2.5.2 Asthma & COPD Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Asthma & COPD Production Market Share by Regions
3.1 Global Asthma & COPD Production Market Share by Regions
3.2 Global Asthma & COPD Revenue Market Share by Regions (2014-2019)
3.3 Global Asthma & COPD Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Asthma & COPD Production
3.4.1 North America Asthma & COPD Production Growth Rate (2014-2019)
3.4.2 North America Asthma & COPD Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Asthma & COPD Production
3.5.1 Europe Asthma & COPD Production Growth Rate (2014-2019)
3.5.2 Europe Asthma & COPD Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Asthma & COPD Production (2014-2019)
3.6.1 China Asthma & COPD Production Growth Rate (2014-2019)
3.6.2 China Asthma & COPD Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Asthma & COPD Production (2014-2019)
3.7.1 Japan Asthma & COPD Production Growth Rate (2014-2019)
3.7.2 Japan Asthma & COPD Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Asthma & COPD Consumption by Regions
4.1 Global Asthma & COPD Consumption by Regions
4.2 North America Asthma & COPD Consumption (2014-2019)
4.3 Europe Asthma & COPD Consumption (2014-2019)
4.4 China Asthma & COPD Consumption (2014-2019)
4.5 Japan Asthma & COPD Consumption (2014-2019)

5 Global Asthma & COPD Production, Revenue, Price Trend by Type
5.1 Global Asthma & COPD Production Market Share by Type (2014-2019)
5.2 Global Asthma & COPD Revenue Market Share by Type (2014-2019)
5.3 Global Asthma & COPD Price by Type (2014-2019)
5.4 Global Asthma & COPD Production Growth by Type (2014-2019)

6 Global Asthma & COPD Market Analysis by Applications
6.1 Global Asthma & COPD Consumption Market Share by Application (2014-2019)
6.2 Global Asthma & COPD Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Asthma & COPD Business
7.1 GSK
7.1.1 GSK Asthma & COPD Production Sites and Area Served
7.1.2 Asthma & COPD Product Introduction, Application and Specification
7.1.3 GSK Asthma & COPD Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Novartis
7.2.1 Novartis Asthma & COPD Production Sites and Area Served
7.2.2 Asthma & COPD Product Introduction, Application and Specification
7.2.3 Novartis Asthma & COPD Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Merck
7.3.1 Merck Asthma & COPD Production Sites and Area Served
7.3.2 Asthma & COPD Product Introduction, Application and Specification
7.3.3 Merck Asthma & COPD Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Abbott
7.4.1 Abbott Asthma & COPD Production Sites and Area Served
7.4.2 Asthma & COPD Product Introduction, Application and Specification
7.4.3 Abbott Asthma & COPD Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Asthma & COPD Production Sites and Area Served
7.5.2 Asthma & COPD Product Introduction, Application and Specification
7.5.3 Boehringer Ingelheim Asthma & COPD Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 AstraZeneca
7.6.1 AstraZeneca Asthma & COPD Production Sites and Area Served
7.6.2 Asthma & COPD Product Introduction, Application and Specification
7.6.3 AstraZeneca Asthma & COPD Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Roche
7.7.1 Roche Asthma & COPD Production Sites and Area Served
7.7.2 Asthma & COPD Product Introduction, Application and Specification
7.7.3 Roche Asthma & COPD Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Teva
7.8.1 Teva Asthma & COPD Production Sites and Area Served
7.8.2 Asthma & COPD Product Introduction, Application and Specification
7.8.3 Teva Asthma & COPD Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Vectura
7.9.1 Vectura Asthma & COPD Production Sites and Area Served
7.9.2 Asthma & COPD Product Introduction, Application and Specification
7.9.3 Vectura Asthma & COPD Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Pfizer
7.10.1 Pfizer Asthma & COPD Production Sites and Area Served
7.10.2 Asthma & COPD Product Introduction, Application and Specification
7.10.3 Pfizer Asthma & COPD Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
7.11 Mylan
7.12 Allergan
7.13 Cipla
7.14 Akorn

8 Asthma & COPD Manufacturing Cost Analysis
8.1 Asthma & COPD Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Asthma & COPD
8.4 Asthma & COPD Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Asthma & COPD Distributors List
9.3 Asthma & COPD Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Asthma & COPD Market Forecast
11.1 Global Asthma & COPD Production, Revenue Forecast
11.1.1 Global Asthma & COPD Production Growth Rate Forecast (2019-2025)
11.1.2 Global Asthma & COPD Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Asthma & COPD Price and Trend Forecast (2019-2025)
11.2 Global Asthma & COPD Production Forecast by Regions (2019-2025)
11.2.1 North America Asthma & COPD Production, Revenue Forecast (2019-2025)
11.2.2 Europe Asthma & COPD Production, Revenue Forecast (2019-2025)
11.2.3 China Asthma & COPD Production, Revenue Forecast (2019-2025)
11.2.4 Japan Asthma & COPD Production, Revenue Forecast (2019-2025)
11.3 Global Asthma & COPD Consumption Forecast by Regions (2019-2025)
11.3.1 North America Asthma & COPD Consumption Forecast (2019-2025)
11.3.2 Europe Asthma & COPD Consumption Forecast (2019-2025)
11.3.3 China Asthma & COPD Consumption Forecast (2019-2025)
11.3.4 Japan Asthma & COPD Consumption Forecast (2019-2025)
11.4 Global Asthma & COPD Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Asthma & COPD Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer